Synergistic Agent for General Medical AI
The status, timeline and source of this project. A free account opens every field.
Source: EU Funding & Tenders Portal
Artificial intelligence (AI) holds immense potential for revolutionizing radiology by enhancing diagnostic accuracy, efficiency, and personalized patient care. However, current AI applications are limited to only specialized taskArtificial intelligence (AI) holds immense potential for revolutionizing radiology by enhancing diagnostic accuracy, efficiency, and personalized patient care. However, cu
- Status
- Under Construction
- Sector
- Hospital, Power Transmission, Bridge, Power Generation (CCGT), Government
- Location
- Germany
- Updated
- 22 Jul 2026
- Source
- EU Funding & Tenders Portal
ConstructChat
Ask ConstructChat about Synergistic Agent for General Medical AI
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | ongoing |
Taiyo status | Under Construction |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Artificial intelligence (AI) holds immense potential for revolutionizing radiology by enhancing diagnostic accuracy, efficiency, and personalized patient care. However, current AI applications are limited to only specialized taskArtificial intelligence (AI) holds immense potential for revolutionizing radiology by enhancing diagnostic accuracy, efficiency, and personalized patient care. However, current AI applications are limited to only specialized tasks, thus failing to capture the complexity of radiological practice, which requires integrating multimodal data and nuanced decision-making. My vision with SAGMA is to develop an agent-based General Medical AI (GMAI) system that overcomes these limitations by combining specialized AI models with generalized reasoning capabilities. The project is structured around three central objectives: 1. Develop specialized image analysis AI models in a scalable manner by leveraging large language models (LLMs) to extract structured data from existing radiological reports. This will enable efficient training across various radiological tasks using unstructured clinical data. 2. Assemble a GMAI system using a LLM as an agent that coordinates the specialized AI models, incorporates uncertainty estimates, and integrates additional tools such as clinical guidelines and laboratory values. This system will utilize multimodal inputs to support comprehensive decision-making. 3.Validate the utility of the agent-based system in realistic clinical settings by assessing its impact on diagnostic accuracy, efficiency, and the overall radiological workflow, ensuring acceptance by clinical experts. By achieving these objectives, SAGMA will bridge the gap between current AI capabilities and the multifaceted nature of radiological practice. The project will demonstrate how an agent-based GMAI system can augment and empower human expertise, potentially transforming radiology and paving the way for similar advancements in other medical specialties. |
Location
Country | Germany |
Source
Source | EU Funding & Tenders Portal |
URL |
More Details
Record type | Project |
Sector | Hospital, Power Transmission, Bridge, Power Generation (CCGT), Government |
Article published date | 2026-02-01 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Hospital projects in Germany
- Boehringer Ingelheim’s New Tablet Production Facility, Ingelheim
- Hameln Pharma Sterile Facility
- Takeda Pharmaceutical Manufacturing Facility, Oranienburg
- Merck Serono Biopharmaceutical R&D Facility Expansion, Darmstadt
- Evonik’s Pharmaceutical Lipids Manufacturing Facility, Hanau, Germany
- Wacker Chemie Biologics Production Facility
- Boehringer Ingelheim Biologicals Development Centre (BDC), Biberach, Germany
- Haupt Pharma, New Packaging Line
